
Alex Warren
@alexfwarren
ICU doctor. @NIHResearch Doctoral Training Fellow @ICNARC / @CCPMG_Team / @bartspom working to improve outcomes in cardiogenic shock. Own views.
ID: 324034792
25-06-2011 21:48:04
3,3K Tweet
1,1K Takipçi
3,3K Takip Edilen

📣 It’s essential we develop a nationally commissioned network for the management of cardiogenic shock & the provision of MCS in the UK 🇬🇧 - despite pressure from Intensive Care Society 💙 British Cardiovascular Society British Heart Foundation & others this is still desperately needed 🤔👉





Collective action is unfortunately the only thing trusts/ employers like University Hospitals Birmingham listen to Strong resolve from doctors 💪🏾 An important message to employers who adopt cheap tactics And reminder to doctors to organise and negotiate EC rates to actually match workload

@aldomatariMD NHS England Roy Lilley 💙 There's poor evid that hospital league tables work. Prof Tom Marshall et al wrote this articl 22 yrs ago & it's still v relevant Wes Streeting Department of Health and Social Care "Performance league tables: the NHS deserves better" pmc.ncbi.nlm.nih.gov/articles/PMC64… 𒊓𒅂𒁓𒐗𒐕𒐗 Steve the skeptic @CraigNikolic David Oliver (also on Blue Sky) Sebastian Rees


Very nice overview of the current state of affairs in cardiogenic shock (published this week in The Lancet):


Really important work from #BOXtrial team - SCAI classification is as applicable to OHCA population as CS for acute and medium term outcome #AHA Alastair Proudfoot Segun Olusanya (He/Him) [email protected]





Great summary from Ed Barnard Ed Barnard of the EAAA RAID Group innovation for OHCA POCUS and SPEAR Great work by Shad on both of these papers



Only 25% of F2 doctors successfully entered speciality training in 2022, likely due to a lack of training spots. Hundreds of doctors that are unable to train to be your GP, your surgeon, your psychiatrist. All while the waiting lists are rising. When will Wes Streeting act?


Pulmonary embolism and clot in transit- a proposed algorithm where the role of the Pulmonary Embolism Response Team (PERT) is highlighted for risk stratification and treatment Work led by Marco Zimarino and mario di marino and friends Link to paper ➡️heart.bmj.com/content/early/… Thank


Yes it does for PCT but no evidence for CRP to reduce antibiotic duration. Fantastic editorial by Marion Campbell to critique methods used and provide perspective on interpretation of secondary analysis explored regarding the strength of the PCT intervention


